Mar 132020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– FRANCE, Nîmes – Advicenne (EPA: ADVIC), a specialty pharmaceutical company focused on the development and commercialization of therapeutic products for orphan renal and neurological diseases, today announced that Dr Luc-André Granier has left his role as CEO of the Company and that the Board of Directors has elected Dr André Ulmann, current Board Observer ...

Advicenne appoints Board Observer Dr André Ulmann as Interim CEO

From:: Advicenne appoints Board Observer Dr André Ulmann as Interim CEO

Sorry, the comment form is closed at this time.